2023
Use of Wearable Devices in Individuals With or at Risk for Cardiovascular Disease in the US, 2019 to 2020
Dhingra L, Aminorroaya A, Oikonomou E, Nargesi A, Wilson F, Krumholz H, Khera R. Use of Wearable Devices in Individuals With or at Risk for Cardiovascular Disease in the US, 2019 to 2020. JAMA Network Open 2023, 6: e2316634. PMID: 37285157, PMCID: PMC10248745, DOI: 10.1001/jamanetworkopen.2023.16634.Peer-Reviewed Original ResearchMeSH KeywordsAdultCardiovascular DiseasesCross-Sectional StudiesFemaleHumansHypertensionMaleMiddle AgedObesityRisk FactorsConceptsHealth Information National Trends SurveyUS adultsExacerbate disparitiesWearable device usersCardiovascular diseaseCardiovascular healthPopulation-based cross-sectional studySelf-reported cardiovascular diseaseCardiovascular disease risk factorsNational Trends SurveyOverall US adult populationCardiovascular risk factor profileSelf-reported accessAssociated with lower useUse of wearable devicesImprove cardiovascular healthLower household incomeLower educational attainmentUS adult populationRisk factor profileNationally representative sampleCross-sectional studyProportion of adultsTrends SurveyWearable device data
2021
Prevalence and trends of coronary artery disease risk factors and their effect on age of diagnosis in patients with established coronary artery disease: Tehran Heart Center (2005–2015)
Hosseini K, Mortazavi S, Sadeghian S, Ayati A, Nalini M, Aminorroaya A, Tavolinejad H, Salarifar M, Pourhosseini H, Aein A, Jalali A, Bozorgi A, Mehrani M, Kamangar F. Prevalence and trends of coronary artery disease risk factors and their effect on age of diagnosis in patients with established coronary artery disease: Tehran Heart Center (2005–2015). BMC Cardiovascular Disorders 2021, 21: 477. PMID: 34607557, PMCID: PMC8491372, DOI: 10.1186/s12872-021-02293-y.Peer-Reviewed Original ResearchConceptsCAD risk factorsRisk factorsTehran Heart CenterOpium useDisease risk factorsEffect of opium useCoronary artery disease risk factorsArtery disease risk factorsMiddle-income countriesYears earlier ageHigher risk of CADHeart CenterCAD diagnosisCross-sectional studyPublic health challengeArtery diseaseAssociated with higher riskBody-mass indexRisk of CADConventional CAD risk factorsAge of CAD onsetLipid profile componentsTraditional risk factorsHypertension prevalenceAge of diagnosisDisparities and spatial variations of high salt intake in Iran: a subnational study of districts based on the small area estimation method
Azadnajafabad S, Ebrahimi N, Mohammadi E, Ghasemi E, Moghaddam S, Aminorroaya A, Rezaei N, Ghanbari A, Masinaei M, Fateh S, Haghshenas R, Gorgani F, Kazemi A, Dilmaghani-Marand A, Farzadfar F. Disparities and spatial variations of high salt intake in Iran: a subnational study of districts based on the small area estimation method. Public Health Nutrition 2021, 24: 6281-6291. PMID: 34261565, PMCID: PMC11148577, DOI: 10.1017/s1368980021002986.Peer-Reviewed Original ResearchMeSH KeywordsAdultCross-Sectional StudiesDietFeeding BehaviorFemaleHumansIranMaleSodium Chloride, DietaryConceptsPrevalence of high salt intakeHigh salt intakeSalt intakeNationwide cross-sectional surveyEstimated prevalenceRisk factor surveillanceEconomic statusNon-communicable diseasesPopulation-wide policiesCross-sectional surveyPublic health issueHigh salt consumptionIran STEPsSocio-economic scaleSmall area estimation methodsStepwise approachDistricts of IranHealth issuesSalt consumptionConcentration indexProvinces of IranRisk factorsIntake measurementsPrevalenceArea estimation methods
2020
Anti-modified citrullinated vimentin antibody: a novel biomarker associated with cardiac systolic dysfunction in patients with rheumatoid arthritis
Norouzi S, Javinani A, Aminorroaya A, Masoumi M. Anti-modified citrullinated vimentin antibody: a novel biomarker associated with cardiac systolic dysfunction in patients with rheumatoid arthritis. BMC Cardiovascular Disorders 2020, 20: 390. PMID: 32847506, PMCID: PMC7448352, DOI: 10.1186/s12872-020-01676-x.Peer-Reviewed Original ResearchConceptsLeft ventricular ejection fractionCardiac systolic dysfunctionCardiovascular diseaseSystolic dysfunctionRheumatoid arthritisReduced left ventricular ejection fractionPredictors of left ventricular ejection fractionAnti-modified citrullinated vimentinEchocardiographic parameters of systolicDisease Activity Score-28Anti-MCV levelsParameters of systolicAssociation of autoantibodiesVentricular ejection fractionConcomitant cardiovascular diseaseExclusion of patientsSusceptibility to cardiovascular diseaseReceiver operating characteristic curveDuration of diseaseCardiovascular disease risk factorsAnti-citrullinated proteinFramingham risk scoreCross-sectional studyTransthoracic echocardiographyDiastolic dysfunction